Combating Alzheimer’s with focused ultrasound drug delivery

Forbes highlights work at the WVU Rockefeller Neuroscience Institute to reduce cerebral amyloid-beta load, a biomarker for neurodegeneration, in patients with Alzheimer’s.

Read the article. 

See additional coverage.